Skip to main content

Homepage

Latest News

IMI launches new Calls for proposals

A new Antimicrobial Resistance (AMR) Accelerator Programme is part of new Calls for proposals launched today by IMI. Of the other topics launched in the Calls, many address brain disorders and immune-mediated diseases. Among other things, the topics aim to make clinical trials more patient-centric, contribute to medicines safety, and apply blockchain technologies to the drug development and health sectors.

/news-events/press-releases/new-antimicrobial-resistance-accelerator-programme-part-latest-imi-calls

Register for IMI 10th Anniversary Scientific Symposium

Register for IMI 10th Anniversary Scientific Symposium  more

Register for IMI Stakeholder Forum 2018

Register for IMI Stakeholder Forum 2018  more

‘The public-private partnership allowed us to do this in a very rapid time frame’ – an interview with WEB-RADR project coordinators

‘The public-private partnership allowed us to do this in a very rapid time frame’ – an interview with WEB-RADR project coordinators  more

 

 

IMI BROCHURE HIGHLIGHTS PROJECT SUCCESSES

IMI projects are accelerating the medicines development process, generating new scientific insights, and developing resources for open use by the research community. Furthermore, some of our projects are already delivering direct benefits to patients. Interested in concrete numbers and examples? Find out more about the impact and outputs of our projects in our new brochure, and learn how we are 'Carrying the torch for medical innovation'.

 more

dna.jpg

 

 

 

WATCH IMI video

Carrying the torch for medical innovation

Diseases keep changing, and infections we treated for decades can once again kill. By bringing together researchers from the public and private sectors, we are working to speed up medicines development and turn knowledge into treatments. Watch our video and share it!